ArticleVaccines2021

Long-Term Follow-Up of Mesothelioma Patients Treated with Dendritic Cell Therapy in Three Phase I/II Trials.

Daphne W Dumoulin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.